Quote:CCR5 inhibition with leronlimab (humanized monoclonal antibody) or maraviroc (small molecule inhibitor) conveyed functional synergy in GBM cell killing by TMZ. Pretreatment with leronlimab enhanced GBM cell killing by RT.
The title of the presentation/abstract told us that Leron aided temozolomide. One would think we already knew pretreatment with Leron enhanced the effect of radiation. Was that already established in earlier trials?
(I guess it's obvious I didn't know that. But in any event it's pretty great.)